{"id":"https://openalex.org/W3014370677","doi":"https://doi.org/10.1002/cpt.1836","title":"The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review","display_name":"The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review","alternate_titles":[],"publication_year":2020,"publication_date":"2020-04-30","ids":{"openalex":"https://openalex.org/W3014370677","doi":"https://doi.org/10.1002/cpt.1836","mag":"3014370677","pmid":"https://pubmed.ncbi.nlm.nih.gov/32236956","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7540323"},"language":"en","primary_location":{"id":"doi:10.1002/cpt.1836","doi":"https://doi.org/10.1002/cpt.1836","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.1836","pdf_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.1836","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3014370677"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.1836","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004254550","display_name":"Liese Barbier","orcid":"https://orcid.org/0000-0003-1786-2080","observed_orcids":["https://orcid.org/0000-0003-1786-2080"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Liese Barbier","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003610646","display_name":"Hans C. Ebbers","orcid":"https://orcid.org/0000-0002-9553-9863","observed_orcids":["https://orcid.org/0000-0002-9553-9863"]},"institutions":[{"id":"https://openalex.org/I4210150351","display_name":"Medicines Evaluation Board","ror":"https://ror.org/05mv4rb84","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210150351"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hans C. Ebbers","raw_affiliation_strings":["Medicines Evaluation Board (MEB) Agency, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicines Evaluation Board (MEB) Agency, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I4210150351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074388972","display_name":"Paul J. Declerck","orcid":"https://orcid.org/0000-0003-1259-9105","observed_orcids":["https://orcid.org/0000-0003-1259-9105"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul Declerck","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047342188","display_name":"Steven Simoens","orcid":"https://orcid.org/0000-0002-9512-2005","observed_orcids":["https://orcid.org/0000-0002-9512-2005"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven Simoens","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016982472","display_name":"Arnold G. Vulto","orcid":"https://orcid.org/0000-0002-8439-2800","observed_orcids":["https://orcid.org/0000-0002-8439-2800"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arnold G. Vulto","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082978640","display_name":"Isabelle Huys","orcid":"https://orcid.org/0000-0002-4738-8298","observed_orcids":["https://orcid.org/0000-0002-4738-8298"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Isabelle Huys","raw_affiliation_strings":["Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5004254550"],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":{"value":3000,"currency":"USD","value_usd":3000},"fwci":2.4216,"has_fulltext":true,"cited_by_count":195,"citation_normalized_percentile":{"value":0.91882456,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"108","issue":"4","first_page":"734","last_page":"755"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9210000038146973},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.9559999704360962},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9990000128746033},{"id":"https://openalex.org/keywords/nocebo-effect","display_name":"nocebo effect","score":0.9800000190734863},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9738398790359497},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8434261679649353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4514736533164978},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3437691032886505},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.32466578483581543},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.15296590328216553},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1436055302619934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.07228049635887146},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.06084245443344116}],"mesh":[{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061214","descriptor_name":"Patient Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1002/cpt.1836","doi":"https://doi.org/10.1002/cpt.1836","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.1836","pdf_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.1836","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/653639","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/653639","pdf_url":"https://lirias.kuleuven.be/bitstream/123456789/653639/2/2020%20CPT%20Barbier_Switchingtobiosimilars_SLR.pdf","source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology & Therapeutics, vol. 108 (4), (734-755)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7540323","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7540323/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Pharmacol Ther","raw_type":"Text"},{"id":"pmid:32236956","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32236956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/387da555-e394-4941-b1c8-7c0267b9dc8b","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/387da555-e394-4941-b1c8-7c0267b9dc8b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology and Therapeutics, 108(4), 734 - 755. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire/387da555-e394-4941-b1c8-7c0267b9dc8b","doi":null,"is_oa":true,"landing_page_url":"https://pure.eur.nl/en/publications/387da555-e394-4941-b1c8-7c0267b9dc8b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Barbier, L, Ebbers, HC, Declerck, P, Simoens, S, Vulto, A & Huys, I 2020, 'The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review', Clinical Pharmacology and Therapeutics, vol. 108, no. 4, pp. 734-755. https://doi.org/10.1002/cpt.1836","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repub.eur.nl:126771","doi":null,"is_oa":true,"landing_page_url":"http://repub.eur.nl/pub/126771","pdf_url":null,"source":{"id":"https://openalex.org/S4377196287","display_name":"RePub (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Pharmacology and Therapeutics","raw_type":"info:eu-repo/semantics/other"}],"best_oa_location":{"id":"doi:10.1002/cpt.1836","doi":"https://doi.org/10.1002/cpt.1836","is_oa":true,"landing_page_url":"https://doi.org/10.1002/cpt.1836","pdf_url":"https://ascpt.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.1836","source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320322308","display_name":"KU Leuven","ror":"https://ror.org/05f950310"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3014370677.pdf","grobid_xml":"https://content.openalex.org/works/W3014370677.grobid-xml"},"referenced_works_count":76,"referenced_works":["https://openalex.org/W43308025","https://openalex.org/W122269675","https://openalex.org/W1147832057","https://openalex.org/W1971471395","https://openalex.org/W1977123599","https://openalex.org/W1986159244","https://openalex.org/W1996429338","https://openalex.org/W2017165606","https://openalex.org/W2024304683","https://openalex.org/W2027927088","https://openalex.org/W2031860350","https://openalex.org/W2052230616","https://openalex.org/W2065055449","https://openalex.org/W2077214492","https://openalex.org/W2080775457","https://openalex.org/W2098398245","https://openalex.org/W2136733759","https://openalex.org/W2148487286","https://openalex.org/W2150065234","https://openalex.org/W2228325863","https://openalex.org/W2287727839","https://openalex.org/W2290587826","https://openalex.org/W2293557195","https://openalex.org/W2325885302","https://openalex.org/W2326662527","https://openalex.org/W2342464058","https://openalex.org/W2342581896","https://openalex.org/W2345220764","https://openalex.org/W2410520654","https://openalex.org/W2410604242","https://openalex.org/W2414366951","https://openalex.org/W2414751009","https://openalex.org/W2508045778","https://openalex.org/W2526345971","https://openalex.org/W2581281042","https://openalex.org/W2610308940","https://openalex.org/W2613074462","https://openalex.org/W2613299853","https://openalex.org/W2623304866","https://openalex.org/W2624289061","https://openalex.org/W2729439821","https://openalex.org/W2735035169","https://openalex.org/W2741340135","https://openalex.org/W2742274814","https://openalex.org/W2748900834","https://openalex.org/W2754032463","https://openalex.org/W2754502404","https://openalex.org/W2759349664","https://openalex.org/W2764082441","https://openalex.org/W2767179430","https://openalex.org/W2768187732","https://openalex.org/W2774116866","https://openalex.org/W2780872292","https://openalex.org/W2786897800","https://openalex.org/W2790246629","https://openalex.org/W2791224008","https://openalex.org/W2793603972","https://openalex.org/W2793866077","https://openalex.org/W2794393158","https://openalex.org/W2799617955","https://openalex.org/W2799634220","https://openalex.org/W2800677642","https://openalex.org/W2801807724","https://openalex.org/W2802364203","https://openalex.org/W2808128519","https://openalex.org/W2808641529","https://openalex.org/W2883444128","https://openalex.org/W2885872617","https://openalex.org/W2889574737","https://openalex.org/W2894239243","https://openalex.org/W2901604941","https://openalex.org/W2913878532","https://openalex.org/W2933622020","https://openalex.org/W2938853148","https://openalex.org/W2947535112","https://openalex.org/W4239442386"],"related_works":["https://openalex.org/W2793866077","https://openalex.org/W4387300093","https://openalex.org/W2786897800","https://openalex.org/W4288009904","https://openalex.org/W2809479701","https://openalex.org/W2626689945","https://openalex.org/W4367335032","https://openalex.org/W2418033422","https://openalex.org/W4293171082","https://openalex.org/W4367181238"],"abstract_inverted_index":{"To":[0],"date,":[1],"no":[2],"consensus":[3],"exists":[4],"among":[5],"stakeholders":[6],"about":[7],"switching":[8,36,40,105,111],"patients":[9,41],"between":[10],"reference":[11],"biological":[12],"products":[13],"(RPs)":[14],"and":[15,37,84,130,157],"biosimilars,":[16],"which":[17,63,139],"may":[18],"have":[19],"been":[20],"curbing":[21],"the":[22,32,88,101,103,148,163],"implementation":[23],"of":[24,59,94,100,147,165],"biosimilars":[25],"in":[26,62,150],"clinical":[27],"practice.":[28],"This":[29],"study":[30],"synthesizes":[31],"available":[33,104],"data":[34,106],"on":[35],"assesses":[38],"whether":[39],"from":[42,66,79,91,112],"a":[43,67,70,92,95,113,116,166],"RP":[44,68,114],"to":[45,69,115,143,153,162],"its":[46],"biosimilar":[47,71,117],"or":[48,54,125],"vice":[49],"versa":[50],"affects":[51],"efficacy,":[52,123],"safety,":[53,124],"immunogenicity":[55,126],"outcomes.":[56],"A":[57],"total":[58],"178":[60],"studies,":[61,102],"switch":[64,154],"outcomes":[65],"were":[72,77,140],"reported,":[73],"was":[74],"identified.":[75],"Data":[76],"derived":[78],"both":[80],"randomized":[81],"controlled":[82],"trials":[83],"real-world":[85],"evidence.":[86],"Despite":[87],"limitations":[89],"stemming":[90],"lack":[93],"robust":[96],"design":[97],"for":[98],"most":[99],"do":[107],"not":[108],"indicate":[109],"that":[110],"is":[118],"associated":[119],"with":[120],"any":[121,151],"major":[122],"issues.":[127],"Some":[128],"open-label":[129],"observational":[131],"studies":[132],"reported":[133],"increased":[134],"discontinuation":[135],"rates":[136],"after":[137],"switching,":[138],"mainly":[141],"attributed":[142],"nocebo":[144,168],"effects.":[145],"Involvement":[146],"prescriber":[149],"decision":[152],"should":[155,159],"remain":[156],"attention":[158],"be":[160],"paid":[161],"mitigation":[164],"potential":[167],"effect.":[169]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3014370677","counts_by_year":[{"year":2026,"cited_by_count":25},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":33},{"year":2023,"cited_by_count":30},{"year":2022,"cited_by_count":34},{"year":2021,"cited_by_count":35},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2020-04-10T00:00:00"}
